Bao et al. demonstrated that a higher expression of ceramide synthase 6 antisense RNA 1 (CERS6-AS1) is significantly associated with tumor grade, clinical stage, and poor prognosis in breast cancer patients [9]. Here, CERS6 is linked to breast carcinoma.